Answer
Repaglinide’s plasma elimination half-life is approximately one hour; after five days of 2 mg three times daily, patients with severe renal impairment (creatinine clearance 20–39 mL/min) had approximately twice the half-life of patients with normal renal function.
Sources for this answer
- Repaglinide 2 mg tabletsViatris (formerly Mylan or Upjohn) · emc · SmPC §5.2 Pharmacokinetic properties · Version 2Document updated
Sources checked